Abstract

CRUZ BARRIOS, María Aida et al. Clinical evolution of patients treated with transfer factor. Rev Cubana Hematol Inmunol Hemoter [online]. 2004, vol.20, n.3, pp. 0-0. ISSN 1561-2996.

We performed a descriptive cross-sectional study in 9 hospitals located in the City of Havana, from April 2001 to April 2002, to evaluate the clinical evolution of 280 patients treated with transfer factor since the effectiveness of this immunostimulant has not been assessed in aftermarket research studies. The rate of relapses occurred one year before and after the treatment was measured. Additionally, data on therapeutic scheme, prescription reasons and immunological tests before and after treatment was collected. The clinical evolution was satisfactory in 43,6 %, partly satisfactory in 39,4 % and unsatisfactory in 16,3 % of cases. Only 41.8 % of cases were applied supplementary tests prior to the prescription, but none was performed afterwards. The treatment with transfer factor improved the clinical evolution of studied patients, although cellular immunodeficiency was not confirmed for all the cases

Keywords : transfer factor; clinical evolution; drug use studies.